ProjectA phase III study of Pomalidomide and low dose Dexamethasone with or without Pembrolizumab (MK3475) in refractory…
Basic data
Title:
A phase III study of Pomalidomide and low dose Dexamethasone with or without Pembrolizumab (MK3475) in refractory or relapsed and refractory Multiple Myeloma
Duration:
09/11/2015 to 08/11/2018
Abstract / short description:
A phase III study of Pomalidomide and low dose Dexamethasone with or without
Pembrolizumab (MK3475) in refractory or relapsed and refractory Multiple Myeloma
Pembrolizumab (MK3475) in refractory or relapsed and refractory Multiple Myeloma
Keywords:
clinical trial
klinische Studie
Involved staff
Managers
Faculty of Medicine
University of Tübingen
University of Tübingen
Cluster of Excellence: Image-Guided and Functionally Instructed Tumor Therapies (iFIT)
Centers or interfaculty scientific institutions
Centers or interfaculty scientific institutions
Contact persons
Department of Radiology
Hospitals and clinical institutes, Faculty of Medicine
Hospitals and clinical institutes, Faculty of Medicine
Local organizational units
Department of Diagnostic and Interventional Radiology
Department of Radiology
Hospitals and clinical institutes, Faculty of Medicine
Hospitals and clinical institutes, Faculty of Medicine
Funders
München, Bayern, Germany